Prior research has demonstrated that the urinary Albumin–Creatinine Ratio (u-ACR) serves as a sensitive biomarker for detecting AKI, and it can predict the risk of AKI earlier than serum creatinine levels alone [25, 26]. This evidence concerns the gene ALB and acute kidney injury.